53 Biggest Movers From Yesterday

Gainers

• IGM Biosciences, Inc. NASDAQ:IGMS shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA NASDAQ:SNY and IGM Biosciences signed an exclusive worldwide collaboration agreement for IgM antibodies agonists against three oncology targets and three immunology/inflammation targets.
• PhaseBio Pharmaceuticals, Inc. NASDAQ:PHAS jumped 46.1% to close at $1.68.
• China SXT Pharmaceuticals, Inc. NASDAQ:SXTC climbed 45.4% to close at $0.2937 on Tuesday after declining 9% on Monday.
• Oblong Inc. NASDAQ:OBLG jumped 45% to close at $0.8410. Oblong posted Q4 net loss of $2.71 million.
• Clever Leaves Holdings Inc. NASDAQ:CLVR gained 40.3% to settle at $2.68.
• MicroVision, Inc. NASDAQ:MVIS climbed 32.8% to close at $5.55. Microvision was granted US patent 'Alteration of resonant mode frequency response in mechanically resonant device.'
• ECMOHO Limited NASDAQ:MOHO gained 28% to settle at $0.32.
• Dave Inc. NASDAQ:DAVE climbed 27.5% to close at $8.31.
• LianBio NASDAQ:LIAN gained 27.5% to settle at $3.57.
• Kinnate Biopharma Inc. NASDAQ:KNTE surged 25.9% to close at $13.06. Kinnate Biopharma posted FY loss of $2.06 per share.
• ShiftPixy, Inc. NASDAQ:PIXY gained 25.6% to settle at $0.8399.
• Blackboxstocks Inc. NASDAQ:BLBX gained 25.6% to close at $2.45.
• Randolph Bancorp, Inc. NASDAQ:RNDB rose 25.4% to close at $26.44 after Hometown Financial Group announced plans to acquire Randolph Bancorp for $27 per share in cash.
• Robinhood Markets, Inc. NASDAQ:HOOD climbed 24.2% to settle at $15.91. Robinhood Markets on Tuesday unveiled extended trading hours for its brokerage platform, building on the company's aim to make investing more accessible for all.
• Auddia Inc. NASDAQ:AUUD gained 23.2% to close at $2.28.
• Ginkgo Bioworks Holdings, Inc. NYSE:DNA rose 22.7% to close at $4.59 after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates.
• Electric Last Mile Solutions, Inc. NASDAQ:ELMS jumped 22.5% to settle at $1.58.
• NeuroSense Therapeutics Ltd. NASDAQ:NRSN surged 22% to close at $4.66.
• Molecular Templates, Inc. NASDAQ:MTEM gained 21.1% to close at $3.27 as the company posted a narrower quarterly loss.
• The Lovesac Company NASDAQ:LOVE shares gained 20.8% to close at $56.99. Lovesac reported fourth-quarter FY22 sales growth of 51.3% year-on-year, to $196.2 million, beating the consensus of $174.33 million.
• Grid Dynamics Holdings, Inc. NASDAQ:GDYN rose 20.5% to close at $14.26.
• Nielsen Holdings plc NYSE:NLSN gained 20.3% to close at $26.72 after the company announced it will be acquire by a private equity consortium led by Evergreen Coast Capital and Brookfield Business Partners for $28 per share.
• Team, Inc. NYSE:TISI jumped 19.4% to settle at $1.91.
• Viracta Therapeutics, Inc. NASDAQ:VIRX gained 18.4% to close at $4.75.
• Guardforce AI Co., Limited NASDAQ:GFAI climbed 17.8% to close at $1.39 after the company announced it is in the process of establishing subsidiaries in Dubai and Australia, with a focus on Robotics as a Service rollout initiatives.
• Genenta Science S.p.A. NASDAQ:GNTA gained 16.8% to close at $7.30.
• Monte Rosa Therapeutics, Inc. NASDAQ:GLUE rose 16.3% to settle at $12.68. Monte Rosa Therapeutics reported a Q4 net loss of $23.4 million.
• TRxADE HEALTH, Inc. NASDAQ:MEDS gained 14.4% to close at $2.62 after the company reported Q4 earnings results.
• Gelesis Holdings, Inc. NYSE:GLS rose 13% to close at $5.49. Gelesis Holdings recently reported FY EPS of $85.22.
• Hycroft Mining Holding Corporation NASDAQ:HYMC shares climbed 11.6% to close at $2.59 after jumping 80% on Monday.
• NexImmune, Inc. NASDAQ:NEXI rose 8.6% to close at $3.52 after declining 24% on Monday.
• Nautilus, Inc. NYSE:NLS gained 8.3% to close at $4.31.

Losers

• NeoGenomics, Inc. NASDAQ:NEO shares tumbled 29.8% to close at $12.49 on Tuesday after the company announced it expects Q1 sales to be below its previously issued guidance range and withdrew its FY22 guidance. The company also announced Mark Mallon has agreed to step down as CEO.
• Aveanna Healthcare Holdings Inc. NASDAQ:AVAH fell 26.7% to close at $3.95 after the company said FY21 EPS results were down from last year. The company also issued FY22 sales guidance below analyst estimates. B of A Securities downgraded the stock from Buy to Neutral and lowered the price target from $10 to $5.5.
• Stryve Foods, Inc. NASDAQ:SNAX shares dipped 24.8% to close at $1.50 after reporting weak quarterly sales.
• Progenity, Inc. NASDAQ:PROG fell 23% to close at $1.24 after reporting Q4 results.
• Soleno Therapeutics, Inc. NASDAQ:SLNO fell 22.8% to close at $0.2220 after the company announced pricing of a roughly $15 million underwritten public offering.
• Lipocine Inc. NASDAQ:LPCN shares dipped 20.3% to close at $1.45. Antares Pharma announced the FDA granted final approval for oral testosterone replacement therapy Tlando for conditions associated with a deficiency or absence of endogenous testosterone, or hypogonadism in adult males. Tlando was developed by Lipocine, with the company exclusively out-licensing the U.S. commercialization rights to Antares.
• Creative Medical Technology Holdings, Inc. NASDAQ:CELZ dropped 19.6% to close at $3.65.
• Uxin Limited NASDAQ:UXIN fell 18.8% to close at $1.21 after the company reported Q3 financial results.
• Terran Orbital Corporation NYSE:LLAP fell 16.4% to close at $9.86.
• Benson Hill, Inc. NYSE:BHIL fell 16.3% to close at $3.35. Barclays maintained Benson Hill with an Overweight and lowered the price target from $10 to $8.
• Ocuphire Pharma, Inc. NASDAQ:OCUP fell 16.2% to close at $3.56 after the company reported topline results from MIRA-3 Phase 3 FDA registration trial for Nyxol® in the reversal of mydriasis.
• Marin Software Incorporated NASDAQ:MRIN fell 15% to close at $3.12 after jumping over 35% on Monday.
• FGI Industries Ltd. NASDAQ:FGI fell 14.8% to close at $3.10 following Q4 results.
• ThermoGenesis Holdings, Inc. NASDAQ:THMO dipped 14.7% to settle at $0.6501 the company reported FY21 sales results were down from last year.
• Allego N.V. NYSE:ALLG fell 14.4% to close at $17.90.
• Kala Pharmaceuticals, Inc. NASDAQ:KALA fell 14.3% to settle at $1.50 following Q4 results.
• SCYNEXIS, Inc. NASDAQ:SCYX dipped 13% to close at $4.09 following Q4 results.
• Kaixin Auto Holdings NASDAQ:KXIN fell 13% to close at $1.27. Kaixin shares jumped over 31% on Monday after the company announced an order for 20,000 electric vehicles.
• Revelation Biosciences, Inc. NASDAQ:REVB dipped 9.3% to close at $2.14.
• Conn's, Inc. NASDAQ:CONN fell 7.1% to settle at $18.96 following Q4 results.
• Save Foods, Inc. NASDAQ:SVFD fell 6.7% to settle at $5.72.